Aegis Therapeutics, LLC Awarded 2nd Patent for Fast Acting Migraine Nasal Spray Treatment
5/14/2013 9:30:17 AM
More...
|
Aegis Therapeutics, LLC Release: Biosuperior Formulations Reduce Industry Concerns About Biosimilar Pricing, Development Costs, and Patient Acceptance
4/2/2013 9:24:09 AM
More...
|
Aegis Therapeutics, LLC Awarded Patent for Absorption-Enhancing Self-Assembling Thixotropic Aqueous Hydrogels
12/12/2012 8:59:23 AM
More...
|
Aegis Therapeutics, LLC Awarded Patent for Fast Acting Intravail®-Based Triptan Nasal Spray Formulations for Treating Migraine Headaches
9/25/2012 8:58:39 AM
More...
|
Aegis Therapeutics, LLC Awarded Patent for Monoclonal Antibody Formulations That Avoid Oxidative Damage Due to Polysorbate Surfactants
7/24/2012 9:10:19 AM
More...
|
Biodel Inc. (BIOD) Obtains Exclusive License to Aegis Therapeutics, LLC' Technologies for Development and Commercialization of Glucagon Pharmaceutical Formulations
6/11/2012 10:43:17 AM
More...
|
Aegis Therapeutics, LLC Awarded Patent for Octreotide Formulations Suitable for Oral and Metered Nasal Spray Delivery
5/21/2012 8:01:22 AM
More...
|
Second Parathyroid Hormone (PTH) Peptide Drug Patent Awarded to Aegis Therapeutics, LLC for Compositions Suitable for Metered Nasal Spray, Oral, and Injectable Delivery
5/17/2012 8:19:00 AM
More...
|
Aegis Therapeutics, LLC Awarded Patent for Interferon Alpha, Beta, and Gamma Formulations That Eliminate Aggregation and Associated Immunogenicity and Are Suitable for Non-Invasive or Injectable Delivery
1/4/2012 8:43:11 AM
More...
|
Aegis Therapeutics, LLC Awarded Patent for Parathyroid Hormone (PTH) Peptide Drug Formulations Suitable for Metered Nasal Spray and Oral Delivery
12/13/2011 8:52:51 AM
More...
|
|